Hussman Strategic Advisors Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 44.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,000 shares of the company’s stock after selling 20,800 shares during the period. Hussman […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has been given an average rating of “Moderate Buy” by the nine analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price […]
Brokerages Set Pacira BioSciences, Inc (NASDAQ:PCRX) Price Target at $58 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) traded up 5.4% on Wednesday . The company traded as high as $35.28 and last traded at $35.22. 255,681 shares were traded during trading, a decline of 54% from the average session volume of 550,619 shares. The stock had previously closed at $33.43. Analyst Ratings Changes PCRX […]